David Feldman is an Adjunct Assistant Professor of Public Service at NYU’s Robert F. Wagner Graduate School of Public Service. He is also the Director of Finance & Operations at Quentis Therapeutics, a NYC based biotechnology company developing novel therapeutics for the treatment of cancer and other rare diseases. Prior to joining Quentis, he held various roles within the biotechnology, healthcare, and investment industries, and has also served as an accounting and financial consultant, advising companies on day-to-day operations and strategy. David began his career at the Big 4 accounting firm KPMG, practicing in both the Audit and Tax groups. He obtained a BS from the University of Vermont, and an MBA from New York University. David is also a licensed CPA and EMT in New York State.
